Log in to search using one of your social media accounts:

 

A Bill to'Eliminate Prostate Cancer Misdiagnosis'A Bill to'Eliminate Prostate Cancer Misdiagnosis '
Who wouldn't want to eliminate the problem of men being wrongly told they had prostate cancer?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 17, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Optimizing Treatment for Castration-Resistant Prostate Cancer Optimizing Treatment for Castration-Resistant Prostate Cancer
Individualizing castration-resistant prostate cancer therapy depends not only on drug profiles but also on patient-related factors. Experts offer a way through the data to reach a clinical decision.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 17, 2017 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Tax Reform Bill Will Bankrupt Community Oncology Centers Tax Reform Bill Will Bankrupt Community Oncology Centers
If Congress passes it, the tax reform bill could cut $25 billion from Medicare, which would drive many community oncology practices into bankrupcy.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 17, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Circulating Vitamin D Concentration and Risk of Seven Cancers Circulating Vitamin D Concentration and Risk of Seven Cancers
Using a comprehensive Mendelian randomization study, the authors sought to determine whether there is a linear association between vitamin D status and cancer risk.The BMJ (formerly known as the British Medical Journal) (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 17, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

APSHO Announces the Inaugural Mary Pazdur Award for Excellence in...
The Advanced Practitioner Society for Hematology and Oncology (APSHO) announces the creation of the Mary Pazdur Award for Excellence in Advanced Practice in Oncology. The annual award will be given to...(PRWeb November 17, 2017)Read the full story at http://www.prweb.com/releases/2017/11/prweb14924369.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 17, 2017 Category: Pharmaceuticals Source Type: news

FDA OKs First Adjuvant Treatment for Kidney Cancer FDA OKs First Adjuvant Treatment for Kidney Cancer
Sunitinib is now approved for use after surgery in renal cell carcinoma patients who are at high risk for disease recurrence.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 16, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

FDA Clears First-in-Class Emicizumab for Hemophilia A FDA Clears First-in-Class Emicizumab for Hemophilia A
Hemlibra is a first-in-class bispecific monoclonal antibody that bridges activated factor IX and X to replace the missing factor VIII.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 16, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

High-Value Cancer Care Keeps Costs Down? Yes, It's Possible! High-Value Cancer Care Keeps Costs Down? Yes, It's Possible!
A preliminary but innovative study looked directly at oncology practices that deliver high-value care at a low cost and identified some of their attributes.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 16, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

FDA Clears Wire-Free Breast Tumor Locator for Long-term Use FDA Clears Wire-Free Breast Tumor Locator for Long-term Use
The SAVI Scout surgical guidance system, a nonradioactive wire-free breast tumor localization device, is now cleared for long-term use.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 16, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

Improved Insurance Access Increases Elective Colon Resection Rates Improved Insurance Access Increases Elective Colon Resection Rates
A new analysis proves that the Massachusetts health insurance'experiment'resulted in better cancer care.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 16, 2017 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Stage III CRC: Which Patients Need 6 Months of Adjuvant Chemo? Stage III CRC: Which Patients Need 6 Months of Adjuvant Chemo?
At the ESMO 2017 Congress in Madrid, Drs Sobrero and Taieb discuss the optimal duration of adjuvant chemotherapy for stage III colon cancer.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 16, 2017 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

MSK-IMPACT Tumor Profiling Test Authorized by FDA MSK-IMPACT Tumor Profiling Test Authorized by FDA
The MSK-IMPACT tumor profiling test is the first multiplex test to receive FDA authorization. The accreditation of the New York State Department of Health as a third-party reviewer provides a path forward for such tests to receive authorization.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 16, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

Early Palliative Care in Advanced Cancer: Who and When? Early Palliative Care in Advanced Cancer: Who and When?
With mounting evidence of benefits from early outpatient specialty palliative care, an international consensus on referral criteria could help clinicians to decide who to refer and when.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 15, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Newer Drugs Have Improved Survival in Prostate Cancer Newer Drugs Have Improved Survival in Prostate Cancer
Newer drugs approved for metastatic prostate cancer prolong both cancer-specific and overall survival relative to historical controls, according to the first population-based study of its kind.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 15, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Researchers to Men With Prostate Cancer: Avoid Whole Milk Researchers to Men With Prostate Cancer: Avoid Whole Milk
The unequivocal advice was offered in the conclusion of a new study of food and prostate cancer recurrence. Another expert disagreed.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 15, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Medical News Today: What you need to know about hypoproteinemia
A look at hypoproteinemia, a condition resulting in low levels of protein in the blood. Included is detail on diagnosis and choosing proteins. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 15, 2017 Category: Consumer Health News Tags: Blood / Hematology Source Type: news

MMR/MSI Testing in Colorectal Cancer'Alarmingly' Low MMR/MSI Testing in Colorectal Cancer'Alarmingly' Low
Testing for mismatch repair (MMR) deficiency is suboptimal despite endorsement and well-established guidelines. Will that change now that immunotherapy is approved?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 14, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

New Techniques to Predict Response to Immunotherapy New Techniques to Predict Response to Immunotherapy
The latest immunotherapy trials suggest that all subgroups benefit, yet not all patients do well. A group of French researchers is tackling this conundrum head-on.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 14, 2017 Category: Consumer Health News Tags: Hematology-Oncology Article Source Type: news

Adjuvant Radiation Benefit in Locally Advanced Thyroid Cancer Adjuvant Radiation Benefit in Locally Advanced Thyroid Cancer
Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - November 14, 2017 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Radiotherapy No Better Than Sorafenib for Inoperable Liver Cancer Radiotherapy No Better Than Sorafenib for Inoperable Liver Cancer
Selective internal radiotherapy (SIRT) with yttrium-90 resin microspheres does not prolong survival compared to sorafenib in patients with advanced hepatocellular carcinoma not eligible for curative treatment, according to French researchers.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - November 14, 2017 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Invitation to Roche ’s live audio webcast and conference call post ASH 2017
We are pleased to invite investors and analysts to participate in a live audio webcast and conference call on Wednesday, 13 December 2017, following the American Society of Hematology Annual Meeting (ASH) in Atlanta (9 – 12 December 2017). (Source: Roche Investor Update)
Source: Roche Investor Update - November 14, 2017 Category: Pharmaceuticals Source Type: news

Queens Medical Associates Adds New Physician
Dr. Abhisek Swaika joins leading oncology and hematology practice(PRWeb November 14, 2017)Read the full story at http://www.prweb.com/releases/2017/11/prweb14919193.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 14, 2017 Category: Pharmaceuticals Source Type: news

Lung Cancer May Grow Faster During Immunotherapy Lung Cancer May Grow Faster During Immunotherapy
A retrospective analysis from France found that 14% of patients with advanced lung cancer showed an acceleration of tumor growth while receiving immunotherapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 13, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Nearly 1 in 3 Breast Cancer Pts Skip Adjuvant Therapy: Why? Nearly 1 in 3 Breast Cancer Pts Skip Adjuvant Therapy: Why?
A general distrust in the healthcare system, but not their personal physician, leads nearly 1 in 3 women with early breast cancer to opt out of or fail to complete adjuvant therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 13, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Gut Microbiome May Be Key Variable in Immunotherapy Efficacy Gut Microbiome May Be Key Variable in Immunotherapy Efficacy
Could an impaired or unbalanced microbiome account for a patient's failure to respond to immunotherapy?Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 13, 2017 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Emerging Therapeutic Strategies in Breast Cancer Emerging Therapeutic Strategies in Breast Cancer
Breast cancer treatment is undergoing a rapid evolution with recent advances in genomics, tumor biology, and immunology. Learn how this translates into new therapeutics in this review.Southern Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 13, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Patient Attitudes Regarding Secondary Germline Findings Patient Attitudes Regarding Secondary Germline Findings
Are patients with advanced cancer interested in learning about secondary germline findings? Are they concerned about clinical and emotional implications of this information?Journal of Oncology Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 13, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

EU Panel Likes Biosimilar Bevacizumab, Other Cancer Agents EU Panel Likes Biosimilar Bevacizumab, Other Cancer Agents
The Committee for Medicinal Products for Human Use has issued a new list of recommendations and rejections for oncology products.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 10, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

CHMP Backs Rurioctocog alfa pegol (Adynovi) for Hemophilia A CHMP Backs Rurioctocog alfa pegol (Adynovi) for Hemophilia A
The European Medicines Agency committee recommended approval of rurioctocog alfa pegol for the treatment and prophylaxis of bleeding in patients aged 12 years and older with hemophilia A.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 10, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

Surgeon Detects His Own Tumor With iPhone/Ultrasound Device Surgeon Detects His Own Tumor With iPhone/Ultrasound Device
A pocket-sized ultrasound device that uses an iPhone for imaging has widespread applications for detecting tumors, among other things.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 10, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

FDA Approves Brentuximab for Cutaneous T-Cell Lymphoma FDA Approves Brentuximab for Cutaneous T-Cell Lymphoma
The drug had significant advantages over two other currently used agents in a phase 3 clinical trial.FDA Approvals (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 9, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

Cancer Drug Parity Laws: A Mixed Bag for Patients Cancer Drug Parity Laws: A Mixed Bag for Patients
Parity laws were passed to help ease the out-of-pocket costs associated with oral agents, but they have not consistently lowered costs.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 9, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Letermovir (Prevymis) Okayed for Stem Cell Transplant Infection Letermovir (Prevymis) Okayed for Stem Cell Transplant Infection
The drug prevents cytomegalovirus infections and disease in adults previously exposed to the common virus who have received an allogeneic hematopoietic stem cell transplant.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 9, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

Combination Therapies: A Tipping Point for Cancer Drug Costs? Combination Therapies: A Tipping Point for Cancer Drug Costs?
Combination treatments are escalating already urgent questions about the cost and value of new cancer drugs.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 9, 2017 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

When Dying Becomes Unaffordable When Dying Becomes Unaffordable
Physician-assisted dying is a highly controversial issue, but patients wishing to end their lives have not been immune to inflated drug costs.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 9, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

UCLA helps many to live long and prosper
In Westwood, more than 100 faculty experts from 25 departments have embarked on anall-encompassing push to cut the health and economic impacts of depression in half by the year 2050. The mammoth undertaking will rely on platforms developed by the new Institute for Precision Health, which will harness the power of big data and genomics to move toward individually tailored treatments and health-promotion strategies.On the same 419 acres of land, researchers across the spectrum, from the laboratory bench to the patient bedside, are ushering in a potentially game-changing approach to turning the body ’s immune defenses a...
Source: UCLA Newsroom: Health Sciences - November 9, 2017 Category: Universities & Medical Training Source Type: news

FDA Approves Expanded Use of CBC Test
The FDA has approved a complete blood cell (CBC) test — the XW-100 Automated Hematology Analyzer — for use in non-traditional laboratory settings, such as... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 9, 2017 Category: Primary Care Source Type: news

' Unrelenting': 20-Year Recurrence Risks in Breast Cancer'Unrelenting': 20-Year Recurrence Risks in Breast Cancer
Clinicians have new long-term data to use in discussions with patients with estrogen receptor-positive breast cancer who have been treated with 5 years of endocrine therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 8, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Alcohol Is a Cancer Risk, ASCO Says Alcohol Is a Cancer Risk, ASCO Says
The influential American Society of Clinical Oncology has never before formally stated that alcohol is a risk factor for cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 8, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

ASCO: Alcohol Is Cancer Risk ASCO: Alcohol Is Cancer Risk
The influential American Society of Clinical Oncology has never before formally stated that alcohol is a risk factor for cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 8, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

AE Risks With Combined Tx for Advanced Breast CA AE Risks With Combined Tx for Advanced Breast CA
Individual targeted agents carry different degrees of risk for severe toxicities, but early management may prevent or reduce negative effect on quality of life.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 8, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

FDA Approves New CLIA-Waived CBC Test for Faster Results FDA Approves New CLIA-Waived CBC Test for Faster Results
The XW-100 Automated Hematology Analyzer can be used in more healthcare settings by nonmedical personnel, offering faster results for patients and providers.FDA Approvals (Source: Medscape Med Students Headlines)
Source: Medscape Med Students Headlines - November 7, 2017 Category: Universities & Medical Training Tags: Pathology & Lab Medicine News Alert Source Type: news

Time to Have the Talk! Sex and the Cancer Patient Time to Have the Talk! Sex and the Cancer Patient
Sexuality is not a topic that gets a lot of attention among cancer patients, especially in the palliative care setting.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 7, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Should Some Oropharyngeal Cancer Patients Skip Adjuvant Chemo, Radiation With TORS? Should Some Oropharyngeal Cancer Patients Skip Adjuvant Chemo, Radiation With TORS?
For patients with oropharyngeal squamous cell carcinoma (OPSCC) receiving transoral robotic surgery (TORS), adjuvant radiotherapy or chemoradiotherapy (CRT) should be avoided if possible, according to a long-term functional and quality-of-life (QOL) outcomes study.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - November 6, 2017 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Disease Control Prolongs QoL in Advanced Breast Cancer Disease Control Prolongs QoL in Advanced Breast Cancer
A new analysis of data from the PALOMA-2 trial in advanced breast cancer shows that quality of life (QoL) was better for a longer period in patients who had increased progression-free survival.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 6, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Could a Common Blood Thinner Lower Cancer Risk?
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 6, 2017 Category: Cancer & Oncology Tags: Cardiology, Hematology, Oncology, Pharmacy, News, Source Type: news

First Tx for Erdheim-Chester Disease, a Rare Blood Cancer First Tx for Erdheim-Chester Disease, a Rare Blood Cancer
The first FDA-approved treatment for Erdheim-Chester dDisease (ECD), a rare blood cancer, is vemurafenib, a targeted therapy already used in melanoma with BRAF V600E mutations.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 6, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

Fighting Neuroblastoma Like a Superhero
Treatment TermsNeuroblastoma CategoriesChildren's health Author Aliza Inbari Overview VG stands for Vomit Girl, the superhero that Sarah Smith created in her mind when she was a young child undergoing numerous rounds of chemotherapy to treat neuroblastoma, a childhood cancer that develops in the adrenal glands. Hero Imagevg_01.jpg Preview Image Content Blocks Content“Chemotherapy causes patients to vomit frequently so I came up with a superhero for myself: Vomit Girl,” explained Sarah, now a 22-year-old, cancer-free college student. Her best friend’s mom made her a large cape displaying the ...
Source: dukehealth.org: Duke Health News - November 6, 2017 Category: Consumer Health News Authors: dg62 at duke.edu Source Type: news

ESMO's Practice-Changing Lung Cancer Data: Three Experts Discuss ESMO's Practice-Changing Lung Cancer Data: Three Experts Discuss
At ESMO 2017, Jack West discussed new, potentially practice-changing immunotherapy research with Hossein Borghaei and Sanjay Popat.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 6, 2017 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Why Burnout Is So Hard to Fix Why Burnout Is So Hard to Fix
Burnout is a'slippery slope.'Redesigned clinical training and development of resilience skills may help physicians avoid'the slide. 'Journal of Oncology Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 6, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news